Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
about
Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesisPregnancy loss and thrombophilia: the elusive link.Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.A Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the LiteratureHELLP syndrome and its relation with the antiphospholipid syndrome.Management of obstetric antiphospholipid syndrome.Guidelines on the investigation and management of antiphospholipid syndrome.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Top 10 clinical research developments in antiphospholipid syndrome.The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.The challenge of pregnancy for patients with SLE.Antiphospholipid antibodies in stillbirth.The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.Rheological, hemostaseological changes during immunetherapy for prevention of HELLP-syndrome in a patient with elevated phospholipid antibodies.Severe Preeclampsia, Antiphospholipid Syndrome, and Ulnar Artery Thrombosis in a Teenage Pregnancy: A Rare Association
P2860
Q28740531-FA8E6880-4CFE-42A8-96EF-300EB1D7C33DQ34263740-B778197F-7DC4-459B-8D12-F3C01F98761EQ35854768-8E7FB5E6-648A-44CF-834C-B5CC545F8550Q36090804-5C10C09B-0FD1-480B-AA56-81C35FFA7FB2Q37588912-9C40E097-366F-44B7-9A70-53BEA16E54ACQ37959314-E48739CA-D990-4FA9-84DC-DBC0B2674E25Q37982121-DA5B75FD-2EFC-4E60-8C15-2D93A269D1C6Q38092150-C787C549-6BB1-47F7-B4A8-2D9D981F37CEQ38135335-B50D6A3A-7831-46AE-A0E2-BFD302025C9AQ38206947-D9106128-3469-454C-9550-F47B2C61AED8Q38891094-C132F951-66F1-4075-8C8A-0A12432B1D9BQ39612786-E47E0798-4F56-4589-B6EA-DD25502BD59DQ43490656-8A8F02D0-E900-4947-B6C3-6DE75EB619C3Q47128289-E80C0CCB-24A0-4BBF-9C44-617F1D4E4939Q47705852-9D98059C-41F7-4979-AA26-E5D36C7F5CA9Q50449309-F17FEABE-A635-480F-89BF-73811D99A65CQ57493094-2D50FC2A-0264-42EE-8D99-91803E3A5BFB
P2860
Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@en
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@nl
type
label
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@en
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@nl
prefLabel
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@en
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@nl
P2860
P356
P1433
P1476
Report of the Obstetric APS Ta ...... d Antibodies, 13th April 2010.
@en
P2093
Obstetric Task Force
P2860
P304
P356
10.1177/0961203310395054
P577
2011-02-01T00:00:00Z